Selected top pharmaceutical R&D projects based on net present value (NPV) as of August 2023 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Clinical trials
R&D overview
6
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic Industry sectors - expenditure on research and development 2021
- Premium Statistic Top pharmaceutical R&D projects based on net present value August 2023
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
- Premium Statistic Research and development in European pharmaceutical industry by country 2021
- Premium Statistic Total clinical research funding by National Institutes for Health 2013-2024
Top R&D companies
5
- Basic Statistic Global top pharmaceutical companies based on R&D spending 2026
- Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
- Basic Statistic Top pharmaceutical companies in R&D spending growth 2022
- Premium Statistic Leading global contract research organizations based on revenue 2022
- Basic Statistic Roche: participation of patients in clinical trials 2009-2017
Clinical studies
7
- Basic Statistic Increase in clinical trials' complexity 2001-2015
- Premium Statistic Clinical trial success rates by therapeutic area 2020
- Basic Statistic Number of registered clinical studies by location worldwide 2024
- Basic Statistic Percent of registered clinical studies worldwide by location 2024
- Basic Statistic Share of recruiting clinical studies worldwide by location 2024
- Premium Statistic Total number of registered clinical studies worldwide 2000-2024
- Basic Statistic Total number of registered clinical studies with posted results worldwide 2008-2024
Participation
4
- Basic Statistic Top clinical trial participant countries worldwide 2015-19, by share
- Basic Statistic Clinical trial participants U.S. vs. rest of world by therapy area 2015-2019
- Basic Statistic Clinical trial participants gender share worldwide 2015-19, by geographic location
- Basic Statistic Clinical trial participants ethnicity share worldwide 2015-19, by geographic location
Costs and market
7
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic R&D expenditure of new therapeutic drugs 2009-2018
- Basic Statistic Estimated clinical trial cost per patient by therapeutic class 2015-2017
- Basic Statistic Estimated clinical trial cost per drug by therapeutic class 2015-2017
- Premium Statistic CRO market size worldwide forecast 2028
- Premium Statistic Global pharma CRO market size 2015-2024, by pre-clinical, clinical and discovery
- Premium Statistic Size of total U.S. clinical trial supplies market 2016-2025
Approvals, launches, setbacks
6
- Premium Statistic Pharmaceutical industry - number of new substances 1998-2022
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Basic Statistic Key measurements of U.S. CDER drug approvals in 2023
- Basic Statistic FDA first premarket approvals for medtech products granted 2005-2022
- Premium Statistic Projection of top 2024 pharma and biotech launches by revenue 2028
- Basic Statistic Number of unsuccessful Alzheimer’s drugs in development in the U.S. 1998-2017
COVID-19
4
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
- Basic Statistic Number of COVID-19 drugs in development worldwide by phase June 2022
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by phase June 2022
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by type June 2022
Further related statistics
15
- Projection of top global pharmaceutical products by revenue growth 2023
- Top new orphan molecular entities by U.S. sales in 2019
- Top U.S. proton pump inhibitors' revenue market share 2013
- Top U.S. cholesterol-lowering drugs by revenue market share 2013
- Count of first-time medtech approvals granted by FDA 2006-2017
- Revenue of top 20 respiratory brands in the U.S. 2016
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Size comparison of small-moelcule drugs and biologics 2020
- Top U.S. proton pump inhibitors based on prescriptions 2013
- Greece: pharmaceutical products export value 2022, by type
- Global women's health drugs and devices market 2016 and 2023
- Global women's health drugs and devices market share by application 2016 and 2023
- Novartis's biggest sales growth drivers by change in sales 2019-2026
- Leading traditional therapy areas by unit cost change U.S. 2020
Further Content: You might find this interesting as well
Statistics
- Projection of top global pharmaceutical products by revenue growth 2023
- Top new orphan molecular entities by U.S. sales in 2019
- Top U.S. proton pump inhibitors' revenue market share 2013
- Top U.S. cholesterol-lowering drugs by revenue market share 2013
- Count of first-time medtech approvals granted by FDA 2006-2017
- Revenue of top 20 respiratory brands in the U.S. 2016
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Size comparison of small-moelcule drugs and biologics 2020
- Top U.S. proton pump inhibitors based on prescriptions 2013
- Greece: pharmaceutical products export value 2022, by type
- Global women's health drugs and devices market 2016 and 2023
- Global women's health drugs and devices market share by application 2016 and 2023
- Novartis's biggest sales growth drivers by change in sales 2019-2026
- Leading traditional therapy areas by unit cost change U.S. 2020
Evaluate. (August 14, 2023). Selected top pharmaceutical R&D projects based on net present value (NPV) as of August 2023 (in billion U.S. dollars) [Graph]. In Statista. Retrieved April 24, 2024, from https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/
Evaluate. "Selected top pharmaceutical R&D projects based on net present value (NPV) as of August 2023 (in billion U.S. dollars)." Chart. August 14, 2023. Statista. Accessed April 24, 2024. https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/
Evaluate. (2023). Selected top pharmaceutical R&D projects based on net present value (NPV) as of August 2023 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: April 24, 2024. https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/
Evaluate. "Selected Top Pharmaceutical R&d Projects Based on Net Present Value (Npv) as of August 2023 (in Billion U.S. Dollars)." Statista, Statista Inc., 14 Aug 2023, https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/
Evaluate, Selected top pharmaceutical R&D projects based on net present value (NPV) as of August 2023 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/ (last visited April 24, 2024)
Selected top pharmaceutical R&D projects based on net present value (NPV) as of August 2023 (in billion U.S. dollars) [Graph], Evaluate, August 14, 2023. [Online]. Available: https://www.statista.com/statistics/309464/major-pharmaceutical-randd-projects-based-on-net-present-value/